Drugs / Metformin IR
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01434186 Background | May 2012 → Apr 2016 | type 2 diabetes mellitus | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Metformin IR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01434186 ↗ |
| Route | Oral | “Tablet, Oral, 1000 mg -2000 mg, Daily , Day 1 through week 52” NCT01434186 ↗ |